Abstract
Objectives:
Squamous cell carcinoma of the temporal bone is a rare and invariably aggressive tumor with an estimated incidence of one per million per year. Tm1 squamous cell carcinoma (SCC) is the most frequent primary malignant tumor of the temporal bone, but the incidence is as rare as <0.2% of all tumors of the head and neck. It is a rare but threat eningly aggressive tumor, with poor prognosis. Because of the rarity of this disease, there is no large prospective series on staging, treatment, and outcomes. Surgical treatment remains a challenge in the hands of skull base surgeons. The prognosis for patients with this disease has remained poor despite advances in surgical and radio-therapeutic techniques.
Methods:
A retrospective review of the medical records of the patients diagnosed with squamous cell carcinoma of the temporal bone from 2000 to 2007 was performed. This study included 14 patients with unilateral temporal bone tumors.
Results/Conclusions:
Factors evaluated included patient demographics, presenting symptoms, physical examination findings, radiographic findings, surgical treatment, method of reconstruction, surgical complications, histopathologic findings, and the use of postoperative radiation therapy.
Get full access to this article
View all access options for this article.